Cytomegalovirus infection in patients with new onset ulcerative colitis: A prospective study

Hepato-Gastroenterology

Volumn 59, Issue 116, 2012, Pages 1098-1101

  Kim, You Sun ^a   Kim, Young Ho ^b   Kim, Joo Sung ^c   Cheon, Jae Hee ^d   Ye, Byong Duk ^e   Jung, Sung Ae ^f   Park, Young Sook ^g   Choi, Chang Hwan ^h   Jang, Byung Ik ⁱ   Han, Dong Soo ^j   Yang, Suk Kyun ^e   Kim, Won Ho ^d  

^a Inje University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

^f Ewha Womans University School of Medicine   (South Korea)

^g Eulji University   (South Korea)

^h Chung Ang University College of Medicine   (South Korea)

ⁱ Yeungnam University College of Medicine   (South Korea)

^j Hanyang University College of Medicine   (South Korea)

more..

Author keywords

Cytomegalovirus; Inflammation; Ulcerative colitis

Indexed keywords

GANCICLOVIR; MESALAZINE; STEROID;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STAINING; STEROID THERAPY; ULCERATIVE COLITIS;

ADULT; ANTIGENS, VIRAL; COLITIS, ULCERATIVE; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84861390434     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge10217     Document Type: Article

References (23)

1. Powell RD, Warner NE, Levine RS, Kirsner JB: Cytomegalic inclusion disease and ulcerative colitis; report of a case in a young adult. Am J Med 1961; 30:334-340.
2. Papadakis KA, Tung JK, Binder SW, et al.: Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol 2001; 96:2137-2142.
3. Vega R, Bertran X, Menacho M, et al.: Cytomegalovirus infection in patients with inflammatory bowel disease. Am J Gastroenterol 1999; 94:1053-1056.
4. Cottone M, Pietrosi G, Martorana G, et al.: Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 2001; 96:773-775.
5. Criscuoli V, Casa A, Orlando A, et al.: Severe acute colitis associated with CMV: a prevalence study. Dig Liver Dis 2004; 36:818-820.
6. Domenech E, Vega R, Ojanguren I, et al.: Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis 2008; 14:1373-1379.
7. Kishore J, Ghoshal U, Ghoshal UC, et al.: Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol 2004; 53:1155-1160.
8. Kambham N, Vij R, Cartwright CA, Longacre T: Cytomega-lovirus infection in steroid-refractory ulcerative colitis: a case-control study. Am J Surg Pathol 2004; 28:365-373.
9. Goodgame RW: Gastrointestinal cytomegalovirus disease. Ann Intern Med 1993; 119:924-935.
10. Soderberg-Naucler C, Fish KN, Nelson JA: Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus- permissive monocyte-derived macro-phages that are refractory to the antiviral activity of these cytokines. J Clin Invest 1997; 100:3154-3163.
11. Matsuoka K, Iwao Y, Mori T, et al.: Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. Am J Gastroenterol 2007; 102:331-337.
12. Schroeder KW, Tremaine WJ, Ilstrup DM: Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987; 317:1625-1629.
13. Baron JH, Connell AM, Lennard-Jones JE: Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1964; 1:89-92.
14. Ljungman P, Griffiths P, Paya C: Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34:1094-1097.
15. Orvar K, Murray J, Carmen G, Conklin J: Cytomegalovirus infection associated with onset of inflammatory bowel disease. Dig Dis Sci 1993; 38:2307-2310.
16. Hofkin GA, Ting CD: Case report: recurrence of chronic ulcerative colitis induced by intercurrent cytomegalic virus infection. Md Med J 1995; 44:1047-1048.
17. Lortholary O, Perronne C, Leport J, Leport C, Vilde JL: Primary cytomegalovirus infection associated with the onset of ulcerative colitis. Eur J Clin Microbiol Infect Dis 1993; 12:570-572.
18. Hussein K, Hayek T, Yassin K, et al.: Acute cytomegalovirus infection associated with the onset of inflammatory bowel disease. Am J Med Sci 2006; 331:40-43.
19. Onyeagocha C, Hossain MS, Kumar A, Jones RM, Roback J, Gewirtz AT: Latent cytomegalovirus infection exacerbates experimental colitis. Am J Pathol 2009; 175:2034-2042.
20. Pfau P, Kochman ML, Furth EE, Lichtenstein GR: Cytomega-lovirus colitis complicating ulcerative colitis in the steroid-naive patient. Am J Gastroenterol 2001; 96:895-899.
21. Mori T, Mori S, Kanda Y, et al.: Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2004; 33:431-434.
22. Gondo H, Minematsu T, Harada M, et al.: Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation. Br J Haematol 1994; 86:130-137.
23. Dimitroulia E, Spanakis N, Konstantinidou AE, Legakis NJ, Tsakris A: Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease. Inflamm Bowel Dis 2006; 12:879-884.